Surgical and systemic management of endometrial cancer: an international survey

Archives of Gynecology and Obstetrics

Volumn 291, Issue 4, 2015, Pages 897-905

  Fotopoulou, Christina ^a,b   Kraetschell, Robert ^a   Dowdy, Sean ^c   Fujiwara, Keiichi ^d   Yaegashi, Nobuo ^e   Larusso, Domenica ^f   Casado, Antonio ^g   Mahner, Sven ^h   Herzog, Thomas J ⁱ   Kehoe, Sean ^j   Vergote, Ignace ^k   Miller, David Scott ^l   Marth, Christian ^m   Fujii, Shingo ⁿ   Sehouli, Jalid ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c Mayo Clinic   (United States)

^d SAITAMA MEDICAL UNIVERSITY INTERNATIONAL MEDICAL CENTER   (Japan)

^e TOHOKU UNIVERSITY   (Japan)

^f NATIONAL CANCER INSTITUTE   (Italy)

^g HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^h UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

ⁱ NewYork Presbyterian Hospital   (United States)

^j UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^k UNIVERSITY OF LEUVEN   (Belgium)

^l UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^m Universitatskliniken F Hor S   (Austria)

ⁿ Kitano Hospital   (Japan)

more..

Author keywords

Chemotherapy; Endometrial cancer; Lymph node dissection; Survey; Toxicity

Indexed keywords

CARBOPLATIN; CISPLATIN; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; PACLITAXEL; IMMUNOLOGICAL ADJUVANT;

ARTICLE; ASIA; CANADA; CANCER ADJUVANT THERAPY; CANCER SURGERY; CHEMORADIOTHERAPY; ENDOMETRIUM CANCER; EUROPE; GERMANY; HUMAN; KIDNEY VEIN; LYMPH NODE DISSECTION; UNITED KINGDOM; UNITED STATES; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; AGED; CLINICAL PRACTICE; DRUG COMBINATION; ENDOMETRIAL NEOPLASMS; ETHNIC GROUP; FEMALE; GYNECOLOGIC SURGERY; GYNECOLOGICAL EXAMINATION; HEALTH SURVEY; PATHOLOGY; PRACTICE GUIDELINE; PROFESSIONAL PRACTICE; PROSPECTIVE STUDY; QUESTIONNAIRE; REPRODUCIBILITY; STANDARDS; STATISTICS AND NUMERICAL DATA; UTILIZATION;

ADJUVANTS, IMMUNOLOGIC; AGED; CHEMOTHERAPY, ADJUVANT; DIAGNOSTIC TECHNIQUES, OBSTETRICAL AND GYNECOLOGICAL; DRUG THERAPY, COMBINATION; ENDOMETRIAL NEOPLASMS; ETHNIC GROUPS; FEMALE; GUIDELINE ADHERENCE; GYNECOLOGIC SURGICAL PROCEDURES; HEALTH SURVEYS; HUMANS; LYMPH NODE EXCISION; PHYSICIAN'S PRACTICE PATTERNS; PROFESSIONAL PRACTICE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RADIOTHERAPY, ADJUVANT; REPRODUCIBILITY OF RESULTS;

EID: 84924778403     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-014-3510-3     Document Type: Article

References (32)

1. Colombo N, Preti E, Landoni F, Carinelli S, Colombo A, Marini C, Sessa C, ESMO Guidelines Working Group (2013) Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol Suppl 6:vi33–vi38. doi:10.1093/annonc/mdt353
2. ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer. American College of Obstetricians and Gynecologists (2005). Obstet Gynecol 106(2):413-25
3. Mariani A, Dowdy SC, Cliby WA, Gostout BS, Jones MB, Wilson TO et al (2008) Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol 109(1):11–18
4. Walsh CS, Karlan BY (2008) Lymphadenectomy’s role in early endometrial cancer: prognostic or therapeutic? J Natl Cancer Inst 100(23):1660–1661
5. Fotopoulou C, Savvatis K, Kraetschell R et al (2010) Systematic pelvic and aortic lymphadenectomy in intermediate and high-risk endometrial cancer: lymph-node mapping and identification of predictive factors for lymph-node status. Eur J Obstet Gynecol Reprod Biol 149(2):199–203
6. Mariani A, Webb MJ, Keeney GL, Podratz KC (2001) Routes of lymphatic spread: a study of 112 consecutive patients with endometrial cancer. Gynecol Oncol 81(1):100–104
7. Marnitz S, Köhler C (2012) Current therapy of patients with endometrial carcinoma. A critical review. Strahlenther Onkol 188(1):12–20
8. Creutzberg CL, Nout RA (2011) The role of radiotherapy in endometrial cancer: current evidence and trends. Curr Oncol Rep 13(6):472–478
9. Kong A, Johnson N, Kitchener HC, Lawrie TA (2012) Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis. J Natl Cancer Inst 104(21):1625–1634
10. Kitchener HC, Trimble EL (2009) Endometrial Cancer Working Group of the Gynecologic Cancer Intergroup. Endometrial cancer state of the science meeting. IJGC 19(1):134–140
11. Bakkum-Gamez JN, Gonzalez-Bosquet J, Laack NN, Mariani A, Dowdy SC (2008) Current issues in the management of endometrial cancer. Mayo Clin Proc 83(1):97–112
12. ASTEC study group, Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 373(9658):125–136
13. Benedetti Panici P, Basile S, Maneschi F, Alberto Lissoni A, Signorelli M, Scambia G et al (2008) Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 100(23):1707–1716
14. Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N (2010) Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet 375(9721):1165–1172
15. Hirahatake K, Hareyama H, Sakuragi N, Nishiya M, Makinoda S, Fujimoto S (1997) A clinical and pathologic study on paraaortic lymph node metastasis in endometrial carcinoma. J Surg Oncol 65:82–87
16. Mariani A, Dowdy SC, Podratz KC (2009) New surgical staging of endometrial cancer: 20 years later. IJGC 105(2):110–111
17. Bakkum-Gamez JN, Mariani A, Dowdy SC, Weaver AL, McGree ME, Cliby WA et al (2011) The impact of surgical guidelines and periodic quality assessment on the staging of endometrial cancer. Gynecol Oncol 123(1):58–64
18. Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Wárlám-Rodenhuis CC et al (2000) Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post operative radiation therapy in Endometrial Carcinoma. Lancet 355(9213):1404–1411
19. Creutzberg CL, van Putten WL, Koper PC et al (2003) PORTEC Study Group. Survival after relapse in patients with endometrial cancer: results from a randomized trial. Gynecol Oncol 89(2):201–209
20. Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Wárlám-Rodenhuis CC et al (2004) Postoperative Radiation Therapy in Endometrial Carcinoma Trial. Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the postoperative radiation therapy in Endometrial Carcinoma trial. JCO 22(7):1234–1241
21. Nout RA, Putter H, Jürgenliemk-Schulz IM et al (2009) Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial. JCO 27(21):3547–3556
22. Nout RA, Putter H, Jürgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, van der Steen-Banasik EM et al (2010) PORTEC Study Group. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet 375(9717):816–823
23. Nout RA, van de Poll-Franse LV, Lybeert ML, Wárlám-Rodenhuis CC, Jobsen JJ, Mens JW et al (2011) Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial. JCO 29(13):1692–1700
24. Nugent EK, Bishop EA, Mathews CA, Moxley KM, Tenney M, Mannel RS et al (2012) Do uterine risk factors or lymph node metastasis more significantly affect recurrence in patients with endometrioid adenocarcinoma? Gynecol Oncol 125(1):94–98
25. Nout RA, Putter H, Jürgenliemk-Schulz IM et al (2012) Five-year quality of life of endometrial cancer patients treated in the randomised post operative radiation therapy in endometrial cancer (PORTEC-2) trial and comparison with norm data. Eur J Cancer 48(11):1638–1648
26. Aalders J, Abeler V, Kolstad P, Onsrud M (1980) Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol 56(4):419–427
27. Kristina Lindemann, Mathias Onsrud, Gunnar Kristensen, Claes Trope (2012) Survival after radiation therapy for early-stage endometrial carcinoma: The Oslo study revisited after up to 43 years of follow-up. JCO 30, suppl; abstr 5008
28. Kiess AP, Damast S, Makker V, Kollmeier MA, Gardner GJ, Aghajanian C et al (2012) Five-year outcomes of adjuvant carboplatin/paclitaxel chemotherapy and intravaginal radiation for stage I-II papillary serous endometrial cancer. Gynecol Oncol 127(2):321–325
29. Duska LR, Berkowitz R, Matulonis U, Muto M, Goodman A, McIntyre JF et al (2005) A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with “high-risk” endometrial cancer. Gynecol Oncol 96(1):198–203
30. Sehouli J, Lichtenegger W (2004) Management des Endometriumkarzinoms: standards und neue Trends. Der Gynäkologe 37(3):245–256
31. Creasman WT, Mutch DE, Herzog TJ (2010) ASTEC lymphadenectomy and radiation therapy studies: are conclusions valid? Gynecol Oncol 116(3):293–294
32. Wright JD, Barrena Medel NI, Sehouli J, Fujiwara K, Herzog TJ (2012) Contemporary management of endometrial cancer. Lancet 379(9823):1352–1360